News
This article was written by Buy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
TILT Holdings Inc. (OTCQB:TLLTF) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants Lynn Ricci – Head of IR and...
News
This article was written by Follow Power Hedge has been covering both traditional and renewable energy since 2010. He targets primarily international companies of...
News
US The month started with a bang with the US jobs report but the following week is looking a little more subdued, starting with...
News
Overview ORLY stands as a prominent player in the automotive aftermarket industry in the United States. Renowned for its wide range of automotive parts,...
News
Thesis Banco BBVA Argentina (NYSE:BBAR) is one of the largest banks in Argentina. It is positioned to benefit from the ongoing digital transformation and...
News
Investment Thesis Nordstrom (NYSE:JWN) has undergone significant structural changes in its business model recently. We view these structural changes as a pivotal catalyst for...
News
JFrog (NASDAQ:FROG) provides clients with a supply chain software solution. The company has achieved a high amount of organic growth, but as the company...
News
Investment Briefing Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) is a biopharmaceutical company that specializes in developing and commercializing treatments for central nervous system (“CNS”) disorders. The...
News
Baosheng Media Group Holdings Limited (NASDAQ:BAOS) Q2 2023 Results Conference Call August 31, 2023 1:30 AM ET Company Participants Zou Jixin – Baosteel Board...
News
CytoMed Therapeutics (NASDAQ:GDTC) CytoMed Therapeutics (GDCT, or the Company), a Singapore-based biotechnology company trading on the NASDAQ, is developing multiple gamma delta chimeric antigen...
News
Atai Life Sciences (NASDAQ:ATAI) has been making great progress in advancing several drugs from its pipeline on multiple fronts. In particular, it is advancing...
